Abbie Celniker Insider Profile
4 Followers
Abbie Celniker, Director at Carisma Therapeutics, holds 429.98K shares in Carisma Therapeutics (Ticker: CARM), holds 0.00 shares in Dyax Corp (Ticker: DYAX). Most recently, Abbie Celniker Sold ― shares of Carisma Therapeutics on Sep 30, 2016 for an estimated value of $30.09K.
Abbie Celniker's Trading History
| CARMCarisma Therapeutics | Sep 30, 2016 | Director | Informative Sell | 30.09K | $4.30K | |
| DYAXDyax Corp | ― | ― | ― | $0.00 |
You May Also Like
Abbie Celniker insider profile FAQ
What is the percentage of profitable transactions made by Abbie Celniker?
The percentage of profitable transactions made by Abbie Celniker is 100%.
What is the average return per transaction made by Abbie Celniker?
The average return per transaction made by Abbie Celniker is 31.30%.
What stocks does Abbie Celniker hold?
Abbie Celniker holds: CARM, DYAX stocks.
What was Abbie Celniker’s latest transaction?
Abbie Celniker’s latest transaction was an Informative Sell of $30.09K.
What was Abbie Celniker's most profitable transaction?
Abbie Celniker’s most profitable transaction was an Informative Sell of CARM stock on September 30, 2016. The return on the trade was 43.50%.
What is Abbie Celniker's role in Carisma Therapeutics?
Abbie Celniker's role in Carisma Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
